Literature DB >> 7251152

Virulence of fungi: correlation of virulence of Blastomyces dermatitidis in vivo with escape from macrophage inhibition of replication in vitro.

E Brummer, P A Morozumi, D E Philpott, D A Stevens.   

Abstract

Strains of Blastomyces dermatitidis which are virulent (V), attenuated (A), or avirulent (AV) in mice have been identified. Virulence of V has been reported to be associated with its ability to replicate in vivo, causing lethal infections in the lungs or in the peritoneal cavity. We report here that V, but not A or AV, has the ability to replicate in vivo in nonlethal subcutaneous lesions. The possibility that V was able to replicate in vivo by evading primary host defenses was investigated. We studied the interaction of macrophages and strains of B. dermatitidis in vitro. In 24-h cocultures, the replication of all three strains of B. dermatitidis was inhibited by macrophages from: (i) untreated mice (20 to 40%), (ii) mice that had recovered from nonlethal blastomycosis (40 to 60%), (iii) concanavalin A-treated mice (50 to 70%), or (iv) peritoneal exudates elicited by thioglycolate (65 to 80%). However, at 72 h in the first three types of cocultures A and AV remained inhibited, whereas V was not inhibited (0 to 4%). Only the most inhibitory macrophages, those induced by thioglycollate, inhibited V at 72 h, though V was again less inhibited than A or AV at that time. Thus, we show a correlation between virulence of V in vivo and its ability to escape from macrophage inhibition of replication in vitro.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251152      PMCID: PMC351523          DOI: 10.1128/iai.32.2.864-871.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

Review 1.  Blastomycosis.

Authors:  G A Sarosi; S F Davies
Journal:  Am Rev Respir Dis       Date:  1979-10

2.  Obfuscation of the activity of antifungal antimicrobics by culture media.

Authors:  P D Hoeprich; P D Finn
Journal:  J Infect Dis       Date:  1972-10       Impact factor: 5.226

3.  Histologic reactions to cell walls of an avirulent and a virulent strain of Blastomyces dermatitidis.

Authors:  R A Cox; L R Mills; G K Best; J F Denton
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

4.  Respiratory infection of laboratory animals with conidia of Blastomyces dermatitidis.

Authors:  J F Denton; A F Di Salvo
Journal:  Mycopathol Mycol Appl       Date:  1968-11-13

5.  Defective tumoricidal capacity of macrophages from C3H/HeJ mice.

Authors:  L P Ruco; M S Meltzer
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

6.  Mouse model of pulmonary blastomycosis: utility, simplicity, and quantitative parameters.

Authors:  R P Harvey; E S Schmid; C C Carrington; D A Stevens
Journal:  Am Rev Respir Dis       Date:  1978-04

7.  Cell wall composition of two strains of Blastomyces dermatitidis exhibiting differences in virulence for mice.

Authors:  R A Cox; G K Best
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

8.  Self-limited blastomycosis: a report of thirteen cases.

Authors:  L D Recht; J R Philips; M R Eckman; G A Sarosi
Journal:  Am Rev Respir Dis       Date:  1979-11

9.  Secretion of lysosomal hydrolases by stimulated and nonstimulated macrophages.

Authors:  J Schnyder; M Baggiolini
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

10.  Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide.

Authors:  C F Nathan; L H Brukner; S C Silverstein; Z A Cohn
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

View more
  18 in total

1.  Mechanisms of fungal pathogenicity: correlation of virulence in vivo, susceptibility to killing by polymorphonuclear neutrophils in vitro, and neutrophil superoxide anion induction among Blastomyces dermatitidis isolates.

Authors:  C J Morrison; D A Stevens
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

2.  Blastomyces dermatitidis yeast cells inhibit nitric oxide production by alveolar macrophage inducible nitric oxide synthase.

Authors:  Nicole M Rocco; John C Carmen; Bruce S Klein
Journal:  Infect Immun       Date:  2011-03-28       Impact factor: 3.441

3.  Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages.

Authors:  D L Granger; J B Hibbs; J R Perfect; D T Durack
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

4.  Evolution of inflammatory response and cellular immune responses in a murine model of disseminated blastomycosis.

Authors:  G S Deepe; C L Taylor; W E Bullock
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

5.  Altered expression of surface protein WI-1 in genetically related strains of Blastomyces dermatitidis that differ in virulence regulates recognition of yeasts by human macrophages.

Authors:  B S Klein; S Chaturvedi; L H Hogan; J M Jones; S L Newman
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

Review 6.  An overview of macrophage-fungal interactions.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1986-02       Impact factor: 2.574

7.  Synergy of itraconazole with macrophages in killing Blastomyces dermatitidis.

Authors:  E Brummer; P R Bhagavathula; L H Hanson; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

8.  Protection against pulmonary blastomycosis: correlation with cellular and humoral immunity in mice after subcutaneous nonlethal infection.

Authors:  P A Morozumi; E Brummer; D A Stevens
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

9.  Enhancing effect of murine polymorphonuclear neutrophils (PMN) on the multiplication of Blastomyces dermatitidis in vitro and in vivo.

Authors:  E Brummer; D A Stevens
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

10.  Susceptibility of Blastomyces dermatitidis strains to products of oxidative metabolism.

Authors:  A M Sugar; R S Chahal; E Brummer; D A Stevens
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.